Tetrabuthylammonium

ID: ALA1236196

Cas Number: 10549-76-5

PubChem CID: 16028

Max Phase: Preclinical

Molecular Formula: C16H36N+

Molecular Weight: 242.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: Tetrabuthylammonium | Tetrabutylammonium|TETRABUTYLAMMONIUM ION|10549-76-5|tetrabutylazanium|1-Butanaminium, N,N,N-tributyl-|N,N,N-tributylbutan-1-aminium|tetra-n-butylammonium|CBU2X6BBJR|CHEMBL1236196|CHEBI:45825|Ammonium, tetrabutyl-|UNII-CBU2X6BBJR|tetrabutyammonium|tetra-butylammonium|tetrabutyl ammonium|tetrabutyl-ammonium|tetra butyl-ammonium|tetra-butyl ammonium|tetra(n-butyl)ammonium|tetra-n-butyl ammonium|Tetrabutylammonium(+1)|TETRABUTHYLAMMONIUM|TAA4|Bu4N+|tetra (n-butyl) ammonium|TetShow More

Synonyms from Alternative Forms(18): Tetrabutylammonium Bromide | Tetrabutylammonium | Tetrabutylammonium Chloride | Tetrabutylammonium Acetate | Tetrabutylammonium Thiocyanate | Tetrabutylammonium Hydrogensulfate | Tetrabutylammonium Iodide | Tetrabutylammonium 2-Hydroxypropanoate | Tetrabutylammonium Fluoride | Tetrabutylammonium Perchlorate | Tetrabutylammonium Methanesulfonate | Tetrabutylammonium Trifluoromethanesulfonate | Tetrabutylammonium 4-Methylbenzenesulfonate | Tetrabutylammonium Dihydrogenphosphate | Tetrabutylammonium Phosphenite | Tetrabutylammonium Hydroxide | Tetrabutylammonium Benzoate | Tetrabutylammonium Tetrafluoroborate

Canonical SMILES:  CCCC[N+](CCCC)(CCCC)CCCC

Standard InChI:  InChI=1S/C16H36N/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4/h5-16H2,1-4H3/q+1

Standard InChI Key:  DZLFLBLQUQXARW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 16  0  0  0  0  0  0  0  0999 V2000
    5.5625   -6.3333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2750   -6.7458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2750   -5.9208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5625   -7.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8458   -5.9208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2708   -7.5708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9917   -6.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8458   -5.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8458   -7.5708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9875   -7.9833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1333   -4.6833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7042   -5.9208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8458   -8.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9833   -8.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1333   -8.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4167   -6.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1333   -3.8583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  1  1  0
  5  1  1  0
  6  2  1  0
  7  3  1  0
  8  5  1  0
  9  4  1  0
 10  6  1  0
 11  8  1  0
 12  7  1  0
 13  9  1  0
 14 10  1  0
 15 13  1  0
 16 12  1  0
 17 11  1  0
M  CHG  1   1   1
M  END

Associated Targets(Human)

SLC22A1 Tchem Solute carrier family 22 member 1 (646 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC22A2 Tchem Solute carrier family 22 member 2 (261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Slc22a1 Solute carrier family 22 member 1 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc22a1 Solute carrier family 22 member 1 (176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc22a2 Solute carrier family 22 member 2 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 242.47Molecular Weight (Monoisotopic): 242.2842AlogP: 5.00#Rotatable Bonds: 12
Polar Surface Area: 0.00Molecular Species: HBA: HBD:
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 1.32CX LogD: 1.32
Aromatic Rings: Heavy Atoms: 17QED Weighted: 0.42Np Likeness Score: 0.12

References

1. Dresser MJ, Gray AT, Giacomini KM..  (2000)  Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).,  292  (1): [PMID:10688634]
2. Sinclair CJ, Chi KD, Subramanian V, Ward KL, Green RM..  (2000)  Functional expression of a high affinity mammalian hepatic choline/organic cation transporter.,  41  (1): [PMID:11060354]
3. Bednarczyk D, Ekins S, Wikel JH, Wright SH..  (2003)  Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.,  63  (1): [PMID:12606755] [10.1124/mol.63.3.489]
4. Dresser MJ, Xiao G, Leabman MK, Gray AT, Giacomini KM..  (2002)  Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).,  19  (1): [PMID:12240953] [10.1023/a:1019870831174]
5. Gorboulev V, Volk C, Arndt P, Akhoundova A, Koepsell H..  (1999)  Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate.,  56  (1): [PMID:10570053] [10.1124/mol.56.6.1254]
6. Urakami Y, Okuda M, Masuda S, Akazawa M, Saito H, Inui K..  (2001)  Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.,  18  (1): [PMID:11758759] [10.1023/a:1013070128668]
7. Zhang L, Gorset W, Dresser MJ, Giacomini KM..  (1999)  The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.,  288  (1): [PMID:10027858]
8. Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, Koepsell H..  (2001)  Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.,  281  (1): [PMID:11502595] [10.1152/ajprenal.2001.281.3.f454]
9. Domingo R, van der Westhuyzen R, Hamann AR, Mostert KJ, Barnard L, Paquet T, Tjhin ET, Saliba KJ, van Otterlo WAL, Strauss E..  (2019)  Overcoming synthetic challenges in targeting coenzyme A biosynthesis with the antimicrobial natural product CJ-15,801.,  10  (12): [PMID:32206243] [10.1039/C9MD00312F]